Heart retransplant recipients with renal dysfunction benefit from simultaneous heart-kidney transplantation
Section snippets
Data source
A retrospective analysis was performed utilizing the United Network for Organ Sharing (UNOS) Standard Transplant Analysis and Research files, updated as of June 30, 2022. From the thoracic transplant recipient file, we identified all adult patients undergoing cardiac retransplantation between January 1, 2005005 and December 31, 20202020, after excluding patients undergoing simultaneous solid-organ transplantation other than kidney. Patients were stratified according to those who underwent
Patient cohort and characteristics
Of the 1,189 patients undergoing heart retransplantation, 251 (21.1%) underwent simultaneous heart-kidney retransplant and 938 (78.9%) underwent isolated heart retransplant. Across the study period, there was increased utilization of simultaneous heart-kidney retransplant (Figure 1): in 2005, simultaneous heart-kidney retransplant accounted for 11.8% (8/68) of all cardiac retransplants compared to 37.0% (37/100) of all cardiac retransplants in 2020 (p < 0.001).
Baseline recipient and donor
Discussion
Heart retransplant recipients remain a high-risk cohort of patients, and thus efforts to enhance outcomes are paramount to optimize organ stewardship. Furthermore, patient selection for simultaneous heart-kidney transplantation requires further study to identify groups deriving true benefit from dual organ transplantation to inform practice policies. As such, our analysis of the UNOS database highlights several important findings. First, simultaneous heart-kidney transplantation has been
Limitations
This analysis of outcomes following simultaneous heart-kidney vs isolated heart retransplantation utilizing the UNOS database has several limitations. Most importantly, baseline renal function was calculated utilizing a single creatinine value prior to transplant, as this was the most reliable marker available within the registry. Therefore, we were unable to quantify the chronicity of renal dysfunction and identify potential markers used clinically to determine potential recoverability of
Conclusion
The utilization of simultaneous heart-kidney transplantation in the setting of cardiac retransplantation has increased dramatically in the United States, accounting for over 33% of all cases in 2020. Significant renal disease in patients requiring heart retransplantation should not be a contraindication to retransplantation, and selected patients with chronic kidney disease and eGFR <45 ml/min/1.73m2 derive a survival benefit from simultaneous kidney transplantation. These findings are
Author contributions
JM, QC, MB, and FE were involved in the study conceptualization and design. JM, QC, and MB conducted the data analysis and drafted the manuscript. All authors were involved in data interpretation, manuscript review, and critical revisions and final approval of the manuscript.
Disclosure statement
Jad Malas and Qiudong Chen are both supported by grants from the National Institutes of Health for advanced heart disease research (T32HL116273). The remaining authors have no relevant financial disclosures.
This work was supported in part by Health Resources and Services Administration contract HHSH250-2019-00001C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of
References (20)
- et al.
The registry of the international society for heart and lung transplantation: Thirty-first official adult heart transplant report–2014; focus theme: retransplantation
J Heart Lung Transplant
(2014) - et al.
Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival
J Heart Lung Transplant
(2009) - et al.
The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics
J Heart Lung Transplant
(2021) - et al.
Consensus conference on heart-kidney transplantation
Am J Transplant
(2021) - et al.
Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions
Am J Kidney Dis
(2010) - et al.
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving global outcomes (KDIGO)
Kidney Int
(2005) - et al.
Predicted heart mass is the optimal metric for size match in heart transplantation
J Heart Lung Transplant
(2019) - et al.
OPTN/SRTR 2020 Annual Data Report: Heart
Am J Transplant
(2022) - et al.
Pre-orthotopic heart transplant estimated glomerular filtration rate predicts post-transplant mortality and renal outcomes: An analysis of the UNOS database
J Heart Lung Transplant
(2016) - et al.
Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors
Ann Thorac Surg
(2011)
Cited by (2)
Heart-kidney transplantation: Is 2 really better than 1?
2023, Journal of Heart and Lung TransplantationEvolutions in Combined Heart-Kidney Transplant
2024, Current Heart Failure Reports